Table 5.
Canonical Pathways involved in healthy aging
| Pathway | # genesa |
# genes in pathwayb |
p-valuec | % Ad |
|---|---|---|---|---|
| Oxidative phosphorylation | 66 | 130 | 0.000 | 50.769 |
| Proteasome | 20 | 31 | 0.000 | 64.516 |
| ATP synthesis | 22 | 40 | 0.000 | 55.000 |
| Infection | 18 | 41 | 0.009 | 43.902 |
| Citrate cycle (TCA cycle) | 12 | 25 | 0.014 | 48.000 |
| Synthesis and degradation of ketone bodies | 5 | 7 | 0.015 | 71.429 |
| RNA polymerase | 11 | 23 | 0.019 | 47.826 |
| Carbon fixation | 10 | 22 | 0.037 | 45.455 |
| Phenylalanine | 6 | 11 | 0.041 | 54.545 |
| Butanoate metabolism | 17 | 44 | 0.044 | 38.636 |
| Amyotrophic lateral sclerosis (ALS) | 8 | 17 | 0.049 | 47.059 |
| Reductive carboxylate cycle (CO2 fixation) | 5 | 9 | 0.056 | 55.556 |
| Valine | 16 | 43 | 0.068 | 37.209 |
| Aminoacyl-tRNA biosynthesis | 10 | 25 | 0.088 | 40.000 |
the number of differentially expressed genes (q < 0.1 by ANOVA) that are members of the pathway
the total number of genes in the pathway
p-values are from a one-tailed Fisher’s Exact Test (see methods)
% abundance of differentially expressed genes in that pathway